Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to −4 randomized trials
Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to −4 randomized trials. // Diabetes Research and Clinical Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0168822726005061?dgcid=rss_sd_all
Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to −4 randomized trials. Diabetes Research and Clinical Practice. https://www.sciencedirect.com/science/article/pii/S0168822726005061?dgcid=rss_sd_all
“Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to −4 randomized trials.” Diabetes Research and Clinical Practice.
@article{article98253,
title = {Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to −4 randomized trials},
journal = {Diabetes Research and Clinical Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0168822726005061?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...